BCM
CO

BlueCrest Capital Management’s Global Cord Blood Corporation CO Stock Holding History

BlueCrest Capital Management’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-748,889
Closed -$2.24M – 370
2023
Q1 		$2.24M Hold
748,889
– – 0.07% 101
2022
Q4 		$2.24M Hold
748,889
– – 0.06% 90
2022
Q3 		$2.24M Sell
748,889
-703,714
-48% -$1.73M 0.07% 110
2022
Q2 		$4.3M Hold
1,452,603
– – 0.17% 73
2022
Q1 		$5.59M Hold
1,452,603
– – 0.18% 76
2021
Q4 		$6.09M Hold
1,452,603
– – 0.2% 85
2021
Q3 		$6.78M Sell
1,452,603
-1,746,397
-55% -$8.57M 0.18% 102
2021
Q2 		$17.1M Buy
3,199,000
+2,969,000
+1,291% +$15.5M 0.32% 59
2021
Q1 		$1.04M Buy
+230,000
New +$998K 0.02% 530

Other funds holding CO

Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
OA
Operose Advisors Milwaukee, Wisconsin $431M AUM 20.45% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BlueCrest Capital Management's CO Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 748,889 shares — an estimated $2.24M sold.

BlueCrest Capital Management first reported a position in CO in Q1 2021 and held it in 9 quarters. The position peaked at $17.1M in Q2 2021. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

  • BlueCrest Capital Management reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 748,889 Global Cord Blood Corporation shares in Q2 2023, an estimated $2.24M.
  • BlueCrest Capital Management first reported a position in Global Cord Blood Corporation in Q1 2021 and held it in 9 quarters.
  • BlueCrest Capital Management's Global Cord Blood Corporation position peaked at $17.1M in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.